PD-L1 IHC validation and comparison of E1L3N & SP142 mAbs in melanoma - Concepedia

Concepedia

Publication | Closed Access

PD-L1 IHC validation and comparison of E1L3N & SP142 mAbs in melanoma

31

Citations

0

References

2015

Year

Kelly Schats, E. van Vré, Stefanie De Schepper, Bart Neyns, Ingrid De Meester, Mark Kockx

Annals of Oncology

Cancer ImmunosurveillanceMedicineMelanomaImmunologyPathologyImmune Checkpoint InhibitorPd-l1 Ihc ValidationImmunotherapyOncologySp142 MabsSkin Cancer

No additional data available for this publication yet. Check back later!